Xunfei Healthcare Technology Co., Ltd.

As of December 31, 2025, Xunfei Healthcare Technology Co., Ltd. carries a market capitalization of 9.56B, placing it among publicly traded companies globally. Its enterprise value stands at 9.53B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Xunfei Healthcare Technology Co., Ltd.'s next confirmed earnings release is scheduled for April 1, 2027.

As of December 31, 2025, Xunfei Healthcare Technology Co., Ltd. has 120.88M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Xunfei Healthcare Technology Co., Ltd. maintains a current ratio of 1.41, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Xunfei Healthcare Technology Co., Ltd.'s stock has declined approximately 25.87% over the past 52 weeks. The 50-day moving average sits at 67.48, while the 200-day moving average is 75.69.

As of December 31, 2025, Xunfei Healthcare Technology Co., Ltd. holds 402.66M in cash and equivalents against 314.93M in total debt, resulting in a net debt position of 173.74M. Total book value stands at 997.79M, with working capital of 548.54M providing operational flexibility.